Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
58,643,980
-
Total 13F shares
-
54,417,973
-
Share change
-
-95,452
-
Total reported value
-
$4,583,620,355
-
Put/Call ratio
-
59%
-
Price per share
-
$84.23
-
Number of holders
-
206
-
Value change
-
-$2,797,515
-
Number of buys
-
114
-
Number of sells
-
75
Institutional Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) as of Q2 2018
As of 30 Jun 2018,
AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) was held by
206 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,417,973 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, Capital International Investors, BB BIOTECH AG, Clearbridge Investments, LLC, STATE STREET CORP, and GOLDMAN SACHS GROUP INC.
This page lists
206
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.